CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Thursday reported third-quarter net income of $947.9 million, after reporting a loss in the same period a year earlier.

The Cambridge, Massachusetts-based company said it had net income of $16.22 per share. Earnings, adjusted for non-recurring gains, came to $4.20 per share.

The biopharmaceutical company posted revenue of $9 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $9.4 million.

Agios Pharmaceuticals shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO